I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Adalimumab and infliximab impair SARS-CoV-2 antibody respon..:
Chanchlani, N
;
Lin, S
;
Chee, D
...
Journal of Crohns & Colitis. , 2021
Link:
http://hdl.handle.net/10044/1/91947
RT Journal T1
Adalimumab and infliximab impair SARS-CoV-2 antibody responses: results from a therapeutic drug monitoring study in 11422 biologic-treated patients
UL https://suche.suub.uni-bremen.de/peid=base-ftimperialcol:oai:spiral.imperial.ac.uk:10044_1_91947&Exemplar=1&LAN=DE A1 Chanchlani, N A1 Lin, S A1 Chee, D A1 Hamilton, B A1 Nice, R A1 Zehra, A A1 Bewshea, C A1 Cipriano, B A1 Derikx, LAAP A1 Dunlop, A A1 Greathead, L A1 Griffiths, RL A1 Ibraheim, H A1 Kelleher, P A1 Kok, KB A1 Lees, CW A1 MacDonald, J A1 Sebastian, S A1 Smith, PJ A1 McDonald, TJ A1 Irving, PM A1 Powell, N A1 Kennedy, NA A1 Goodhand, JR A1 Ahmad, T PB Oxford University Press YR 2021 K1 Science & Technology K1 Life Sciences & Biomedicine K1 Gastroenterology & Hepatology K1 CLARITY K1 biologic K1 infliximab K1 adalimumab K1 vedolizumab K1 COVID-19 K1 immunosuppression K1 vaccination K1 inflammatory bowel disease K1 INFLAMMATORY-BOWEL-DISEASE K1 TNF K1 MATURATION K1 DEFICIENT K1 ALPHA K1 Adult K1 Antibody Formation K1 Biological Products K1 Drug Monitoring K1 Humans K1 Inflammatory Bowel Diseases K1 Male K1 SARS-CoV-2 K1 Seroepidemiologic Studies K1 Tumor Necrosis Factor Inhibitors JF Journal of Crohns & Colitis LK http://hdl.handle.net/10044/1/91947 DO http://hdl.handle.net/10044/1/91947 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)